Portfolio of Weight Loss Drug Stocks

The following table lists 3 weight loss drug stocks.

3 Weight Loss Drug Stocks

Name & Return

& Snapshot

AstraZeneca AZN
Eli Lilly LLY
Novo Nordisk NVO
Display Price Chart for each stock.
Display Dividend Chart for each stock.

Portfolio Values

To inspect the performance of the Weight Loss Drug Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

All 3 stocks are included in the portfolio computations. The current value of the portfolio assumes that $3,333.33 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of the $10,000 investment is $55,978. The percent return is 459.78%. The annualized return is 41.12%.

Portfolio Value Chart for Last 100 Daily Closes

Related Portfolios

Portfolio of Diet (Weight Loss) Stocks

Portfolio of Fitness Center Stocks

Portfolio of Natural and Organic Food Stocks

Portfolio of Nutritional Supplements Stocks

Portfolio of Vitamin and Supplement Stocks